Endologix Inc
ELGX
ELGX was delisted on the 15th of July, 2020.
111 hedge funds and large institutions have $431M invested in Endologix Inc in 2017 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 40 increasing their positions, 33 reducing their positions, and 32 closing their positions.
21% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 33
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
14% less funds holding
Funds holding: 129 → 111 (-18)
37% less capital invested
Capital invested by funds: $688M → $431M (-$257M)
56% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 32
99% less call options, than puts
Call options by funds: $7K | Put options by funds: $639K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$21.5M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$20.9M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$8.83M |
| 4 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
+$4.27M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$3.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
TimesSquare Capital Management
New York
|
-$27.6M |
| 2 |
ClearBridge Investments
New York
|
-$19M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$10.2M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$9.41M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.35M |
ELGX Hedge Fund Activity: Q2 2017 in Review
111 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Endologix Inc (ELGX) for Q2 2017, worth a combined $431M — down 37% from $688M a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of ELGX and 14 opened new positions — a net loss of 18 holders — while 33 trimmed existing stakes and 40 added.
The largest buyer was Redmile Group, adding an estimated $21.5M. The largest seller was TimesSquare Capital Management, exiting entirely with an estimated $27.6M sold.
- 111 institutional investors held Endologix Inc (ELGX) as of Q2 2017, down from 129 in Q1 2017.
- Funds reported $431M of Endologix Inc stock for Q2 2017, down 37% quarter-over-quarter.
- 14 funds opened new Endologix Inc positions in Q2 2017 and 32 closed out, a net change of -18 holders.
- The largest Endologix Inc buyer in Q2 2017 was Redmile Group, an estimated $21.5M added.
- The largest Endologix Inc seller in Q2 2017 was TimesSquare Capital Management, an estimated $27.6M sold.
Based on aggregated 13F filings for Q2 2017.